A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.
Néboa ZozayaJavier VillasecaIrene FernándezFernando Maurício Francis AbdallaBenito Cadenas-NoreñaMiguel Ángel Ma Calleja-HernándezPedro Gómez-PajueloJorge Mestre-FerrandizJuan OlivaJosé Luis TrilloÁlvaro Hidalgo-VegaPublished in: Applied health economics and health policy (2024)
Most analysed countries show a trend towards value-based approaches that consider value for money to society, but also other economic, clinical, and humanistic criteria. Good practices included robustness, transparency, independence, and participation.
Keyphrases